Socialiya - Entertainment. Knowledge. Community.
Roche Licenses Nurix Therapeutics Blood-Cancer Drug for Up to $2.3 Billion

The deal expands Roche's pipeline in oncology and potentially other therapeutic areas.

BUSINESS NEWS June 08, 2026

Roche Licenses Nurix Therapeutics Blood-Cancer Drug for Up to $2.3 Billion

The deal expands Roche's pipeline in oncology and potentially other therapeutic areas.

2 views 0 likes 0 comments
Share:
The deal expands Roche's pipeline in oncology and potentially other therapeutic areas.

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya